Description
NADROBARA® Nadroparin 2850 IU Prefilled Syringe
Preventive anticoagulation plays a critical role in modern clinical practice, particularly in reducing the risk of thromboembolic complications in surgical and immobilized patients. Low molecular weight heparins (LMWH) are widely used in Libyan healthcare settings due to their predictable anticoagulant response and favorable safety profile.
NADROBARA® (Nadroparin Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA). The 2850 IU strength is specifically designed for thromboprophylaxis, supporting hospitals, clinics, and healthcare professionals in Tripoli, Benghazi, Misrata, and across Libya — To Share • To Care • To Inspire.

Reviews
There are no reviews yet.